VALIANT LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Valiant Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.11₹ -0.92
As on Oct 31, 2025, 4:00 PM IST
Valiant Laboratories Price Performance
Today's LowToday's High
₹80.81₹83.77
₹82.08
52 Weeks' Low52 Weeks' High
₹75.69₹124.44
₹82.08
Open Price
₹83.00
Prev. Close
₹83.00
Volume
1,681
Over the last 5 years, the share price of Valiant Laboratories has declined 12.15% CAGR. Over the past year, the corresponding return has been -24.12%.
Valiant Laboratories’s current P/E of 3,568.70x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Valiant Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Valiant Laboratories | -6.19 | -1.85 | -10.39 | -11.44 | -24.12 | -19.42 | -12.15 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Valiant Laboratories has declined 24.12% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Valiant Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Valiant Laboratories Financials
Valiant Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 86.09 | 84.61 |
| 10 | 84.75 | 84.79 |
| 20 | 84.2 | 84.87 |
| 50 | 85.79 | 86.62 |
| 100 | 93.3 | 89.54 |
| 200 | 91.74 | 94.97 |
Valiant Laboratories Share Holding Pattern
In the latest quarter, Valiant Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding fell to 0.02%, and public shareholding moved up to 25.05% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Valiant Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 08, 2025, 6:13 AM IST | Valiant Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 30, 2025, 9:55 PM IST | Valiant Laboratories - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulatio |
| Sep 26, 2025, 9:08 PM IST | Valiant Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 25, 2025, 11:18 PM IST | Valiant Laboratories - Announcement under Regulation 30 (LODR)-Change in Management |
| Sep 25, 2025, 11:10 PM IST | Valiant Laboratories - Shareholder Meeting / Postal Ballot-Outcome of AGM |
About Valiant Laboratories
Valiant Laboratories Ltd. is a Public Limited Listed company incorporated on 06/08/2021 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24299MH2021PLC365904 and registration number is 365904. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 133.36 Cr. and Equity Capital is Rs. 43.45 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address104, Udyog Kshetra, Mulund Goregaon Link Road, Mumbai Maharashtra 400080
- Contact
Management
- Mr. Santosh S VoraManaging Director
- Mr. Paresh S ShahExecutive Director & CFO
- Mr. Shantilal S VoraNon Executive Director
- Mr. Sandeep N GuptaNon Executive Director
- Mrs. Sonal A ViraInd. Non-Executive Director
- Mr. Mulesh M SavlaInd. Non-Executive Director
- Mr. Ashok ChhedaInd. Non-Executive Director
FAQs on Valiant Laboratories Share Price
What is the share price of Valiant Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Valiant Laboratories is ₹82.08 as on Oct 31, 2025.
What kind of stock is Valiant Laboratories?
The Valiant Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Valiant Laboratories?
The market cap of Valiant Laboratories is ₹445.80 Cr as on Oct 31, 2025.
What are today's High and Low prices of Valiant Laboratories?
Today’s highest and lowest price of Valiant Laboratories are ₹83.77 and ₹80.81.
What are the 52 Week High and 52 Week Low of Valiant Laboratories?
The 52-week high/low is the highest and lowest price at which Valiant Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Valiant Laboratories is ₹124.44 and 52-week low of Valiant Laboratories is ₹75.69 as on Oct 31, 2025.
How has the Valiant Laboratories performed historically in terms of returns?
The Valiant Laboratories has shown returns of -1.11% over the past day, -1.85% for the past month, -10.39% over 3 months, -24.12% over 1 year, -19.42% across 3 years, and -12.15% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Valiant Laboratories?
P/E ratio of and PB ratio of Valiant Laboratories are 3,568.70 and 1.41 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse